Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence R Boone

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitorsLawrence R Boone
Current Opinion in Investigational Drugs (London, England : 2000)|November 16, 2010
Antiretroviral drug development for HIV: challenges for the futureLawrence R Boone, George W Koszalka
Antimicrobial Agents and Chemotherapy|October 28, 2005
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistanceRichard J Hazen, Robert J Harvey, Marty H St Clair, et al.
Journal of Medicinal Chemistry|January 20, 2006
Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitorKaren R Romines, George A Freeman, Lee T Schaller, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorRobert G Ferris, Richard J Hazen, Grace B Roberts, et al.
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitorsLawrence R Boone
Current Opinion in Investigational Drugs (London, England : 2000)|November 16, 2010
Antiretroviral drug development for HIV: challenges for the futureLawrence R Boone, George W Koszalka
Antimicrobial Agents and Chemotherapy|October 28, 2005
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistanceRichard J Hazen, Robert J Harvey, Marty H St Clair, et al.
Journal of Medicinal Chemistry|January 20, 2006
Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitorKaren R Romines, George A Freeman, Lee T Schaller, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorRobert G Ferris, Richard J Hazen, Grace B Roberts, et al.
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Pageof 1